DB16504ExperimentalSmall molecule
BCc1 is a nanomedicine that demonstrated potent anticancer effects in both in vitro and in vivo studies.
- Mechanism
- Curator reviewed
BCc1 is a nanocomplex with therapeutic effects that is designed based on nanochelating technology. It is currently being investigated against cancer.
- Code names
- BCc1
What you can answer from here — as of March 06, 2025
Which companies are running trials of BCc1, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account